PBYI — Puma Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Puma Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	112	93.4	82.1	81.1	95.9
Net Total Accounts Receivable
Net Total Receivables	28.9	28.9	32.5	42.3	47.8
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	166	146	140	134	156
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.8	18.9	15.8	12.5	8.65
Net Intangible Assets
Other Long Term Assets
Total Assets	235	244	227	222	231
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	90.8	114	110	77.5	99.4
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	217	250	229	200	177
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	17.5	-5.95	-2.45	21.6	53.4
Total Liabilities & Shareholders' Equity	235	244	227	222	231
Total Common Shares Outstanding